摘要
目的:探讨丹红注射液联合依达拉奉对急性高血压性脑出血患者的临床疗效与安全性。方法:将50例急性脑出血患者随机分为两组,对照组采用常规治疗,治疗组在常规治疗基础上加用丹红注射液和依达拉奉。结果:治疗组治愈率和好转率均较对照组明显提高(P〈0.01);神经功能缺损评分改善明显优于对照组(P〈0.01)。结论:丹红注射液联合依达拉奉治疗急性期高血压性脑出血安全有效,值得临床推广应用。
Goal: Discusses the red inoculation fluid according to reach jointly pulls presents to the acute hypertension cerebral hemorrhage patient's clinical curative effect and the security. Method: Divides into two groups stochastically 50 example acute cerebral hemorrhage patient, the control group uses the conventional treatment, the treatment group adds in the conventional treatment foundation with the red inoculation fluid and according to reaches pulls presents. Finally: The treatment group cure rate becoming reconciled rate of rotation compares the control group distinct enhancement.
关键词
丹红注射液
依达拉奉
高血压性脑出血
Red inoculation fluid
According to reaches pulls presents
Hypertension cerebral hemorrhage